TrialSeminars in arthritis and rheumatism2025

Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial.

Michael M Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.